Negative Feedback Regulation of Wnt4 Signaling by EAF1 and EAF2/U19 by Wan, Xiaoyang et al.
Negative Feedback Regulation of Wnt4 Signaling by
EAF1 and EAF2/U19
Xiaoyang Wan, Wei Ji, Xue Mei, Jiangang Zhou, Jing-xia Liu, Chengchi Fang, Wuhan Xiao*
Key Laboratory of Biodiversity and Conservation of Aquatic Organisms, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, People’s Republic of China
Abstract
Previous studies indicated that EAF (ELL-associated factor) family members, EAF1 and EAF2/U19, play a role in cancer and
embryogenesis. For example, EAF2/U19 may serve as a tumor suppressor in prostate cancer. At the same time, EAF2/U19 is
a downstream factor in the non-canonical Wnt 4 signaling pathway required for eye development in Xenopus laevis, and
along with EAF1, contributes to convergence and extension movements in zebrafish embryos through Wnt maintenance.
Here, we used zebrafish embryos and mammalian cells to show that both EAF1 and EAF2/U19 were up-regulated by Wnt4
(Wnt4a). Furthermore, we found that EAF1 and EAF2/U19 suppressed Wnt4 expression by directly binding to the Wnt4
promoter as seen in chromatin immunoprecipitation assays. These findings indicate that an auto-regulatory negative
feedback loop occurs between Wnt4 and the EAF family, which is conserved between zebrafish and mammalian. The rescue
experiments in zebrafish embryos showed that early embryonic development required the maintenance of the appropriate
levels of Wnt4a through the feedback loop. Others have demonstrated that the tumor suppressors p63, p73 and WT1
positively regulate Wnt4 expression while p21 has the opposite effect, suggesting that maintenance of appropriate Wnt4
expression may also be critical for adult tissue homeostasis and prevention against tumor initiation. Thus, the auto-
regulatory negative feedback loop that controls expression of Wnt4 and EAF proteins may play an important role in both
embryonic development and tumor suppression. Our findings provide the first convincing line of evidence that EAF and
Wnt4 form an auto-regulatory negative feedback loop in vivo.
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Introduction
Evidence strongly supports the involvement of EAF (ELL-
associated factor) family members in cancer, particularly in
prostate cancer and acute myeloid leukemia [1,2]. Studies initially
identified EAF1 and EAF2/U19 (Up-regulated gene 19) through
their association with ELL (Eleven-nineteen lysine-rich leukemia),
a fusion partner of MLL in the t (11; 19) (q23; p13.1) chromosomal
translocation associated with acute myeloid leukemia [3,4], while
an independent study simultaneously identified EAF2/U19
through its up-regulation by androgen in the rat prostate [5].
ELL binds to RNA polymerase II and acts as a transcription
elongation factor whose targeted deletion leads to embryonic
lethality in mice [6,7]. By binding to ELL, both EAF1 and EAF2/
U19 efficiently stimulate ELL elongation activity [8]. Luo et al.
found that the ability of ELL-MLL to induce leukemogenesis
requires the EAF1-interaction domain in ELL [2]. As well, we
previously showed through in vitro and in vivo functional assays that
EAF2/U19 serves a tumor suppressive role in prostate cancer
[1,9,10]. EAF2/19 inhibits xenograft prostate tumor growth and is
down-regulated in prostate cancer cell lines. In addition, human
advanced prostate cancer specimens exhibit EAF2/U19 down-
regulation, allelic loss, promoter hypermethylation, and homozy-
gous deletion [1]. Consistent with its potential tumor suppressive
role in the human, Eaf2/U19-knockout mice develop lung
adenocarcinoma, hepatocellular carcinoma, B-cell lymphoma,
and high-grade prostate intraepithelial neoplasia [10]. Moreover,
we recently showed that EAF2/U19 binds to and stabilizes the
classic tumor suppressor, pVHL [11]. While these findings link
EAF proteins to cancer, the molecular mechanisms underlying this
involvement remain unclear.
In addition to cancer, for some species, EAF proteins may also
play an important role in embryogenesis through non-canonical
Wnt signaling [12]. Eaf2/U19 is not required for embryogenesis,
as the intercross between heterozygous mice yielded phenotypi-
cally normal offspring with the expected 1:2:1 genotypic ratios
[10]. However, in Xenopus laevis, normal eye development requires
the expression of the eaf2/u19 gene, a target of non-canonical
Wnt4 signaling [12]. Wnt4 is a member of the Wnt family of
secreted glycoproteins important in tissue and organ organization
during development [13]. Some members of the Wnt family
function by stabilizing b-catenin; this pathway is referred to as
canonical signaling. Other Wnt proteins, such as Wnt4, function
independently of b-catenin and thus are involved in non-canonical
signaling. Evidence supports the involvement of Wnt4 in
embryogenesis. Xenopus, mouse and chicken embryos express
Wnt4 in distinct expression domains in neural tissues as well as the
developing excretory system [12,14]. Similarly, loss-of-function
studies have shown kidney organogenesis in mouse and Xenopus
requires Wnt4 [12,15].
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Ungar and colleagues cloned wnt4a, initially named wnt4, from
zebrafish using an orthologous gene search. Based on the
phenotypes of zebrafish and Xenopus embryos injected with
synthetic mRNA, zebrafish wnt4a and Xenopus Xwnt-5A appear
to share a similar function, distinct from that of wnt1, Xwnt3A and
Xwnt8 [16]. Little is known regarding the function of wnt4b,a
duplicate gene of wnt4a. However, work from Liu et al. has
demonstrated that the zebrafish floor plate exclusively expresses
wnt4b mRNA and that sonic hedgehog and gli-2 zebrafish mutants
alter this expression [17]. In non-canonical Wnt signaling,
zebrafish Wnt4a appears to be much closer to that of mammalian
Wnt4 [18].
During function assays for the Eaf gene family in zebrafish
embryogenesis, we found that Eaf1 and Eaf2/U19 could regulate
gene expression of the non-canonical Wnt signaling ligands, wnt5,
wnt11, wnt11r and wnt4 [19]. Given that EAF2/U19 is downstream
of Wnt4 in Xenopus laevis [12], we hypothesized that a regulation
loop may exist between the EAF family and the non-canonical
Wnt signaling ligand, Wnt4. Using zebrafish embryos and
mammalian cell line 293, we found that Wnt4 up-regulated both
EAF1 and EAF2/U19, while both EAF1 and EAF2/U19
efficiently suppressed Wnt4 expression, supporting the existence
of an auto-regulatory negative feedback loop.
Materials and Methods
Maintenance of Fish Stocks and Embryo Collection
Breeding wild-type zebrafish (Danio rerio) (AB) were maintained
and embryos rose under standard library conditions approved by
the research committee of Institute of Hydrobiology, CAS.
Cell Lines and Plasmid Construction
HEK 293 cells were obtained from ATCC. Cells were
maintained in Dulbecco Modified Eagle Medium (Gibco) with
10% fetal bovine serum (FBS, Hyclone), 1% Glutamine, and 1%
penicillin-streptomycin (Hyclone) at 37uC in a humidified
atmosphere containing 5% CO2.
Human Wnt4 cDNA, provided by Andrew McMahon, was
cloned into the vector pCGN-HAM (provided by William
Tansey). Human EAF1 and EAF2/U19 were also subcloned into
pCGN-HAM. Zebrafish eaf1, eaf2/u19 and wnt4a were RT-PCR
amplified and subcloned into both the Psp64 poly(A) vector
(Promega) and the CMV-Myc vector (Clontech) (The PCR primer
sequences will be provided upon request). Human Wnt4 promoter
luciferase constructs (pGL2-Basic) (2.6kb and 1.2 kb) were
provided by Paul Goodyer. The promoter regions for zebrafish
eaf1 (212882+69), zebrafish eaf2/u19 (26632+337), human
EAF2/U19 (232222+436) and human EAF1 (+6162+262) were
PCR amplified and subcloned into a pGL3-Basic vector
(Promega). All constructs were verified by sequencing. The cell
line transient transfections were carried out using Lipofectamine
2000 (Invitrogen).
Luciferase Reporter Assays
For zebrafish eaf1 and eaf2/u19 promoter assays, zebrafish
embryos were injected with the indicated amounts of vectors and
the Renilla luciferase reporter as an internal control. For human
Eaf1 and Eaf2/U19 promoter assays, 293 cells grown on 24-well
plates were transfected with the indicated amounts of vectors and
the Renilla luciferase reporter as an internal control, using
Lipofectamine 2000. The luciferase activity in embryos lysates or
cell extracts was determined 24 hours post fertilization (hpf) or 24–
30 hours post transfection using the Dual-luciferase Reporter
Assay System (Promega). The relative light units were measured
using a luminometer (Sirius, Zylux Corporation, Oak Ridge, TN).
Data were normalized by Renilla luciferase. Data are reported as
mean 6 SEM of three independent experiments performed in
triplicate. The statistical analysis (paired t-test) was performed
using GraphPad Prism 5.
Morpholino Injection, mRNA Synthesis and In Situ
Hybridization
Morpholinos against zebrafish eaf1 (EAF1-MO1) and eaf2/u19
(EAF2-MO1) were described previously [19]. Morpholino against
zebrafish wnt4a (Wnt4-MO) was also described previously [18].
MRNA synthesis and whole mount in situ hybridization were
performed as described previously [19].
Semi-Quantitative RT-PCR
Using the RNeasy Mini Kit (Qiagen), we isolated total RNA
from wild-type zebrafish embryos and embryos that had been
injected with wnt4a mRNA, GFP mRNA (100 pg), zebrafish eaf1
mRNA (100 pg), zebrafish eaf2/u19 mRNA(100 pg), EAF1-
MO1(8 ng), Eaf2-MO1(8 ng) or Standard Morpholino (STD-
MO) (8 ng). The RevertAid
TM First Strand cDNA Synthesis Kit
(Fermentas, Burlington, Ontario) and random primers were used
to reverse transcribe 2 mg RNA. As a template for the semi-
quantitative RT-PCR, we used first strand cDNA corresponding
to 50 ng of total RNA. Semi-quantitative PCR was performed in
the presence of SYBR green using a Chromo4
TM Detector for the
PTC DNA Engine
TM System (Bio-Rad). All PCR reactions were
run in triplicate and repeated at least three times. Differences were
calculated according to the DD Ct relative quantization method
using the b-actin gene to calibrate. The primers for zebrafish wnt4a
were 59- TTCAGGCTCCTGGGAAGTCAAGA -39 and 59-
TGCGGCTTGAATTGTGAGTTTCG -39. The primers for
zebrafish eaf1 were 59- ATGATCGAGCAGATGAGCAGCA-
GT-39 and 59- TGTGTTCATCAGCTGGTTGTTGCC-39. The
primers for zebrafish eaf2 were 59- TGGAAGGATCCACAG-
CACCAGTTA-39 and 59- TGCTCCAGCCGTGACTGAATC-
TTA-39. The primers for zebrafish b-actin gene included 59-
CACTGTGCCCATCTACGAG -39 and 59- CCATCTCCT-
GCTCGAAGTC -39. We used GraphPad Prism 5 for statistical
analysis (paired t-test).
Antibodies and Western Blot Analysis
Polyclonal antibodies against human EAF1 and EAF2/U19
were raised in rabbit. Briefly, full length human EAF1 (aa 1–268)
and EAF2/U19 (aa 1–260) were cloned into the pET-32a vector
(Novagen) and then the vectors transformed in the Escherichia coli
strain BL21 (DE3). The His-tagged EAF1 and EAF2/U19
proteins were induced by 1 mM isopropyl b-D-thiogalactoside,
run through a column filled with His.Bind Resin (Novagen) and
then eluted in buffer consisting of 1 M imidazole, 500 mM NaCl,
and 20 mM Tris-HCl (pH 7.9). The purified fusion protein was
dialyzed against Tris-buffered saline (TBS; pH 7.5) overnight.
Rabbits were immunized three times with the purified His-tagged
EAF1 or EAF2/U19 mixed with Freund adjuvant. Anti-a-tubulin
monoclonal antibody was purchased from Upstate. Anti-b-actin
antibody, anti-GAPDH and anti-myc antibody were purchased
from Santa Cruz. Anti-HA (monoclonal) was purchased from
Covance Research Products (Cumberland, Virginia).
Western blots were performed as described previously [9]. A
FujiFilm LAS4000mini luminescent image analyzer was used to
photograph blots. Quantitative analysis was performed using a
Multi Gauge v3.0 in addition to a LAS4000mini analyzer. We
Wnt4 Regulation
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analysis (paired t-test).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed
according to a modified protocol from the acetyl-histone H3
immunoprecipitation kit manual (Upstate). 293 cells were cross-
linked with 1% formaldehyde in PBS for 2 min at room
temperature, washed three times with cold PBS, and then scraped
off the plate. Scraped cells were lysed with lysis buffer that
included proteinase inhibitors and 1 mM dithiothretol. Cell lysates
were sonicated to break down chromatin into pieces 200–500 base
pairs in length. Chromatin was diluted 1:10, and pre-cleared with
protein A agarose beads (Upstate) for 1 h at 4uC. Approximately
3% of the chromatin from each sample was saved as input and the
rest used for immunoprecipitation with polyclonal rabbit anti-
EAF1, anti-EAF2/U19 or preimmune serum as a control at 4uC
overnight. Immunoprecipitated antibody–protein–DNA complex-
es were collected by protein A agarose beads at 4uC for 1 h and
then extensively washed. The complex was eluted and reverse
cross-linked at 65uC for 6 h, and then proteinase K added for a
further incubation at 45uC for 1 h. DNA samples were extracted
using phenol:chloroform. PCR was performed for 35 cycles with
the following cycling condition: 94uC, 30 s; 53uC, 30 s; 72uC,
1 min. The reactions included primers for the human Wnt4
promoter (59- CCTGGTAGCCTGGCAAATCTTCC -39 and 59-
TCCCATGGTCTTCCCTCCTTGTGA -39) or for the promot-
er region of b-actin (59-CAGGGCGTGATGGTGGGCA-39 and
59- CAAACATGATCTGGGTCATCTTCTC -39), which was
used as internal control. The locations of primers are indicated.
Northern Blot Analysis
293 cells were transfected with the pCGN-HAM empty vector,
or vectors expressing HA-EAF1 or HA-EAF2/U19. Total RNA
was isolated with Trizol reagent (Invitrogen). Electrophoresis,
transfer and hybridization were performed as described previously
[5]. The membrane was probed using synthesized oligos
corresponding to human Wnt4 (59-atggccttggacgtcttgttgcatgt-39)
and human b-actin (59-atgtgcaatcaaagtcctcggccaca-39) labeled
with biotin at the 39 end. The signal was detected using the
North2South Nucleus Labeling and Detection Kit (Pierce).
Photography and data analysis were done as described for the
Western blot analysis.
Results
Zebrafish Eaf1 and Eaf2/u19 Are Wnt4a Downstream
Factors
We had shown that during zebrafish embryogenesis, eaf1 and
eaf2/u19 mediated convergence and extension movements as well
as midline convergence of organ primordia by regulating
expression levels of the non-canonical Wnt ligands, wnt5, wnt11
and wnt11r [19]. This corroborated previous studies that had
established roles for wnt5 and wnt11 in regulating convergence and
extension movements [20,21], and wnt11 and wnt11r in midline
convergence of organ primordia [18]. To gain a more complete
picture of Eaf1 and Eaf2/U19-mediated regulation of non-
canonical Wnt ligands, we had also evaluated the expression of
wnt4a mRNA in the Eaf1 and Eaf2 morphants. Surprisingly, in
contrast to other non-canonical ligands (wnt5, wnt11 and wnt11r),
morpholino-mediated Eaf1 and Eaf2/U19 knockdown resulted in
an increase in wnt4a expression. Given that others had also shown
that eaf2/u19 is downstream of Wnt4 in Xenopus [12], we set forth
to further explore the relationship between EAF proteins and
Wnt4a.
To investigate the relationship between Wnt4a and the Eaf
family we first injected zebrafish embryos with wnt4a mRNA and
then performed whole-mount in situ hybridization to determine the
eaf1 and eaf2/u19 expression patterns. Consistent with the
observation of eaf2/u19 up-regulation by wnt4 in Xenopus, ectopic
wnt4a mRNA increased eaf2/u19 mRNA levels in the zebrafish
embryo at 6-somite (Data not shown), 12-somite (Fig. 1B, the third
column from left to right) and 18-somite stages (Data not shown).
Ectopic wnt4a mRNA also led to an increase in eaf1 expression at
12-somite stage (Fig. 1A, the third column from left to right). On
the contrary, the expression of eaf1 and eaf2/u19 was down-
regulated in the embryos injected with Wnt4a antisense morpho-
lino—Wnt 4a-MO [18] (Fig. 1A and 2B, the second columns from
left to right). Semi-quantitative RT-RCR confirmed the ability of
Wnt4a to up-regulate eaf1 and eaf2/u19 expression significantly as
well as showed that Wnt4a induced more eaf2/u19 expression than
eaf1 (Fig. 1C and 1D, two columns at the right). Consistently, the
knockdown of Wnt4a by Wnt4a-MO injection caused down-
regulation of both eaf1 and eaf2/u19 (Fig. 1C and 1D, two columns
at the left).
To further verify the up-regulation of Eaf family members by
Wnt4a, we did promoter assays. We cloned approximately 1.2 kb
of the zebrafish eaf1 promoter and 1.0 kb of the eaf2/u19 promoter
into a pGL3-Basic vector (Fig. 2A & 2C). The resultant eaf1 and
eaf2/u19 promoter reporter constructs were then co-injected with
either a Myc-empty vector or Myc-tagged wnt4a vector into
zebrafish embryos, along with a Renilla control. After 24 hpf, we
did luciferase assays using embryo lysates. Introduction of the
wnt4a vector increased the transcriptional activity of the eaf1
promoter by about 1.8-fold (Fig. 2B) and the eaf2/u19 promoter by
about 3-fold (Fig. 2E), consistent with the results obtained by
whole-mount in situ hybridization and RT-PCR analysis (Fig. 1A
& 1B). Western blot analysis confirmed Wnt4a protein expression
(Fig. 2D). To rule out the possibility that Wnt4a non-specifically
induced luciferase expression, we co-injected the pGL3-Basic
vector with either the Myc-empty or Myc-tagged wnt4a vector.
Wnt4a did not affect the baseline level of luciferase activity, further
supporting the ability of Wnt4a to specifically induce eaf1 and eaf2/
u19 promoter activity (Data not shown).
Zebrafish Eaf1 and Eaf2/u19 Knockdown Rescued
Embryo Defects Caused by Ectopic Wnt4a
To investigate whether the biological effects of Wnt4a are
mediated by Eaf1 and Eaf2/U19 in vivo, we performed a
phenotype analysis in zebrafish embryos. To knockdown expres-
sion, we injected embryos with morpholinos against eaf1 (EAF1-
MO1) and eaf2/u19 (EAF2-MO1) that we had previously shown to
be both efficient and specific [19]. As a control, we used the
standard morpholino, STD-MO as we had previously demon-
strated that injection with this morpholino does not alter zebrafish
phenotype [19]. Injection of zebrafish embryos at the one-cell
stage with synthetic wnt4a mRNA (100 pg) coupled with STD-MO
resulted in about 33.9% of the embryos (Fig. 3Aa and Fig. 3Bc)
exhibiting cyclopia (Fig. 3Ab), misfolding in the brain (Fig. 3Ac),
and an anterior forking notochord (Fig. 3Ac) accompanied with a
shortened axis (Fig. 3Ad): these defects resemble those caused by
wnt4a mRNA injection alone [16]. However, when we included a
combination of EAF1-MO1 (4 ng) and EAF2-MO1 (4 ng), only
about 10% of the embryos exhibited defects (Fig. 3Ba and 3Bc),
while the majority of the embryos appeared morphologically
normal (Fig. 3Bb), similar to the wild-type embryos. The ability of
EAF1-MO1 and EAF2-MO1 to rescue the phenotype induced by
Wnt4 Regulation
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These results further support the likelihood that Eaf1 and Eaf2/
U19 serve as downstream mediators of Wnt4a signaling, consistent
with results obtained in Xenopus laevis [12].
Zebrafish Eaf1 and Eaf2/u19 Suppress Wnt4a Expression
Given our previous observation that Eaf1 and Eaf2/U19
knockdown resulted in the up-regulation of wnt4a expression
[19], we wanted to further evaluate the effect of Eaf1 and Eaf2/
U19 on wnt4a gene expression. We first determined the wnt4a
expression pattern during zebrafish embryogenesis by whole
mount in situ hybridization. The wnt4a transcript was initially
detected in the dorsocaudal region of the forebrain at the earlier
stage of somitogenesis, and then appeared in the dorsal and lateral
regions of the caudal hindbrain and the neural plate (Data not
shown), the same pattern as reported previously [16]. Next, we
injected zebrafish eaf1 mRNA into embryos at the one-cell stage.
At 12-somite stage, the expression of wnt4a decreased (Fig. 4A, the
second column from left to right) (n=24/33 at 12-somite stage).
Similarly, wnt4a mRNA expression decreased in eaf2/u19 mRNA-
injected embryos (Fig. 4A, the third column from left to right)
(n=22/36 at 12-somite stage). Then, we injected antisense
morpholinos against either zebrafish eaf1 or eaf2/u19 into embryos
at the one-cell stage. The expression of wnt4a increased by either
the eaf1-knockdown (Fig. 4A, the forth column from left to right)
(n=29/36 at 12-somite stage) or the eaf2/u19-knockdown (Fig. 4A,
the fifth column from left to right) (n=29/29 at 12-somite stage).
Interestingly, the eaf2/u19-knockdown caused the expression of
wnt4a increased more significant than that of eaf1-knockdown at
the 12-somite stage (Fig. 4A, the forth and fifth columns from left
to right). To confirm these results, we employed semi-quantitative
real-time PCR to analyze levels of wnt4a in embryos. The results
indicate that injection of either eaf1 mRNA (p=0.0172) or eaf2/
u19 mRNA (p=0.0187) dramatically suppressed wnt4a gene
expression at 12-somite stage (Fig. 4Ba). As expected, blocking
Eaf1 or Eaf2/U19 expression by morpholinos dramatically up-
regulated wnt4a mRNA levels (Fig. 4Bb). Together, this data
suggests that Eaf1 and Eaf2/U19 inhibit wnt4a transcription
efficiently.
Mammalian EAF1 and EAF2/U19 Are Wnt4 Downstream
Factors
After demonstrating a relationship between the Eaf family and
Wnt4a in zebrafish, we next wanted to determine if this
Figure 1. Both zebrafish eaf1 and eaf2/u19 genes are downstream factors of zebrafish Wnt4a. (A) Zebrafish embryos were injected with
Wnt4-MO and wnt4a mRNA and the levels of zebrafish eaf1 mRNA determined by whole-mount in situ hybridization at 12-somite stage. (B) Zebrafish
embryos were injected with Wnt4-MO and wnt4a mRNA and the levels of zebrafish eaf/u19 mRNA determined by whole-mount in situ hybridization.
12s, 12 somites. (C) Semi-quantitative RT-PCR analysis of eaf1 expression in zebrafish embryos (12 somites) injected with Wnt4a-MO and wnt4a
mRNA. (D) Semi-quantitative RT-PCR analysis of eaf2/u19 expression in zebrafish embryos (12 somites) injected with Wnt4a-MO and wnt4a mRNA.
doi:10.1371/journal.pone.0009118.g001
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PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9118Figure 2. Zebrafish wnt4a can activate the zebrafish eaf1 and eaf2/U19 promoters. (A) The sequence of the 1.2 kb zebrafish eaf1 promoter
and the positions of primers used for subcloning. The transcriptional initial site is indicated by +1. (B) Zebrafish embryos were co-injected with the
eaf1 promoter reporter and either a control vector or a vector expressing Myc-Want4a. The luciferase activity was normalized to Renilla and reported
as the mean 6 standard deviation (SD). (C) The sequence of the 1.0 kb zebrafish eaf2/u19 promoter and the primers used for subcloning. The
transcriptional initial site is indicated by +1. (D) The expression of Myc-Wnt4a was verified by Western blot using an anti-Myc antibody. (E) Zebrafish
embryos were co-injected with the eaf2/u19 promoter reporter and either a control vector or a vector expressing Myc-Wnt4a. The luciferase activity
was normalized to Renilla and reported as the mean 6 SD.
doi:10.1371/journal.pone.0009118.g002
Wnt4 Regulation
PLoS ONE | www.plosone.org 5 February 2010 | Volume 5 | Issue 2 | e9118relationship exists in mammalian cells; thus, we performed similar
assays in the mammalian 293 cell line. As a first step, we cloned
the human EAF1 and EAF2/U19 promoter regions into the pGL3-
basic vector (Fig. 5A and 5D). EAF1 and EAF2/U19 reporter
constructs were then co-transfected with either an HA-empty
vector or HA-tagged Wnt4 vector along with the Renilla control
into 293 cells. Wnt4 increased the transcriptional activity of the
EAF1 promoter by about 5-fold (Fig. 5B) and the EAF2/U19
promoter by about 14-fold (Fig. 5E); similar to what we had seen
in the zebrafish eaf1 and eaf2/u19 promoter assays (Fig. 2B & E)
and consistent with the increase of EAF2/U19 induced by
Wnt4 in Xenopus laevis [12]. Western blot analysis confirmed
Wnt4 protein expression (Fig. 5C). To rule out the possibility
that Wnt4 non-specifically induced the pGL3-basic vector, we
performed a control experiment in which we co-transfected cells
with the pGL3-basic vector and either the HA-empty vector or the
HA-tagged wnt4 vector. We found that HA-Wnt4 did not change
the level of luciferase activity (Data not shown). These observations
indicate that Wnt4 can directly induce the EAF1 and EAF2/U19
genes in mammalian cells.
To determine if Wnt4 over-expression also increased the protein
levels of EAF1 and EAF2/U19 in mammalian cells, we conducted
Western blot analysis of 293 cells transfected with an HA-empty
vector or an expression vector for HA-tagged Wnt4. Anti-EAF1 or
anti-EAF2/U19 polyclonal antibodies revealed that Wnt4 induced
a dramatic increase in both EAF1 and EAF2/U19 levels
(p,0.0001) (Fig. 6A and 6B). Consistent with the promoter assays,
Wnt4 induced expression of more EAF2/U19 than EAF1 protein.
Mammalian EAF1 and EAF2/U19 Suppress Wnt4
Expression
Of note, EAF1 and EAF2/U19 are nuclear proteins that harbor
transactivation domains [1,3,4,9]; thus, we hypothesized that
EAF1/2 might be able to act as transcriptional repressors for
wnt4a, despite the fact that these proteins possess transactivation
domains. To test this possibility, we performed Wnt4-promoter
reporter assays in 293 cells. 293 cells were co-transfected with the
pGL2-Basic vector (control), the pGL2-1.2 kb (2122822 36)
Wnt4-promoter reporter or the pGl2-2.6 kb Wnt4-promoter
reporter [13]coupled with the HA-empty vector (control), or
vectors expressing HA-EAF1 or HA-EAF2/U19. Figure 7A shows
that co-transfection of either EAF1 or EAF2/U19 inhibited
activity of both the 1.2 kb and the 2.6 kb Wnt4 promoter. The
inhibition, except in the case of co-transfection of EAF1 with the
1.2 kb Wnt4 promoter, was statistically significant (Fig. 7A). In
contrast, EAF1 and EAF2/U19 induced transcriptional activity of
the pGL2-Basic empty vector, ruling out the possibility of a non-
specific inhibition of EAF proteins on the Wnt4 promoter.
We next carried out Northern blot analysis to confirm the
suppressive effect of EAF1 and EAF2/U19 on Wnt4 transcription in
293cells.AsshowninFigure7Baand7Bb,comparedtothecontrol,
ectopic overexpression of either HA-EAF1 or HA-EAF2/U19
decreased Wnt4 mRNA. Notably, EAF2/U19 had a greater effect,
which is consistent with of the results from the promoter assays
(Fig. 7A). The protein expression of HA-EAF1 and HA-EAF2/U19
was verified by Western blot analysis (Fig. 7C). Together, the data
demonstrate that EAF1 and EAF2/U19 suppress Wnt4 expression
in mammalian cells, perhaps in a direct manner.
Human EAF1 and EAF2/U19 Bind to Wnt4 Promoter In
Vivo
To test whether EAF1 or EAF2/U19 binds directly to the Wnt4
promoter in vivo, we did a ChIP analysis. We immunoprecipitated
Figure 3. The knockdown of zebrafish Eaf1 and Eaf2/U19
rescues the embryonic defects caused by wnt4a over-expres-
sion. (A) Zebrafish embryos were co-injected with wnt4a mRNA (10 pg)
and standard morpholino (STD) (8 ng). Defects, indicated by red arrows,
included (b) folking notochord, (c) cyclopia, and (d) shortened axis. (B) (a)
The embryos were co-injected with wnt4a mRNA and Eaf1/2-MO1to
rescue the phenotype resembles wild-type embryos. (b) An example of a
rescued embryo.(c)Theefficiency of the Eaf1/Eaf2-MO1-mediated rescue
is statistically significant (p,0.05) by counting defective embryos.
doi:10.1371/journal.pone.0009118.g003
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antibody or an EAF2/U19-specific antibody. The precipitated
chromatin was then analyzed using a primer pair that amplified a
segment of the Wnt4 promoter (21406 to 21102) (Figure 8B). A
segment of b-actin promoter amplified by a specific primer pair
was used as a control. The ChIP assays demonstrated that
endogenous EAF1 and EAF2/U19 proteins bound to the Wnt4
promoter. In contrast, there was no EAF1 or EAF2/U19 protein
bound to the promoter region of b-actin (Figure 8A). Thus, these
data suggest that EAF1 and EAF2/U19 bind directly to the Wnt4
promoter to modulate expression levels.
Discussion
A previous study identified EAF2/U19 as a downstream factor
in the non-canonical Wnt4 signaling important for eye develop-
ment in Xenopus laevis [12]. In this study, through promoter assays,
whole mount in situ hybridization, semi-quantitative PCR,
Western blot analysis and embryo rescue experiments in zebrafish
embryos and mammalian cell lines, we provide additional data
supporting EAF2/U19, as well as EAF1, as downstream factors of
Wnt4. Although we did not provide direct evidence to show that
EAF1 is a downstream factor of non-canonical Wnt4 signaling, the
possibility exists that this is the case based on the conserved
structure and function between EAF1 and EAF2/U19.
The role of Eaf2/U19 in embryogenesis appears to be different
among species. In mouse, Eaf2/U19 gene-targeting did not cause
any detectable defects in embryos [10]. This is not the case in
other species: in Xenopus laevis, eye development requires EAF2/
U19 [12] while in zebrafish, Eaf2/U19 knockdown resulted in a
fusion of the eyes (cyclopia), probably due to a C & E movement
defect [19]. The possibility exists that Eaf2/u19-knockout mice do
not show detectable defects in embryogenesis due to a redundancy
between Eaf1 and Eaf2/U19, but at the same time, we have
evidence that in zebrafish, Eaf1 and Eaf2/u19 are not fully
redundant [19]. Clearly, more studies are required. Even so, the
results from our studies in zebrafish and mammalian cells as well
as studies done in Xenopus cells suggest that the regulation of EAF1
and EAF2/U19 by Wnt4 may be conserved across species, even if
the functional roles of the proteins are not.
In addition to Wnt4 regulating EAF1 and EAF2/U19
expression, we also found that EAF1 and EAF2/U19 bound
directly to the Wnt4 promoter in 293 cells, causing suppression in
Wnt4 expression. These observations led us to propose that Eaf
and Wnt4 form an effective auto-regulatory feedback loop to
maintain an appropriate level of expression (Fig. 9). Based on the
analysis of zebrafish embryos and 293 cells, this auto-regulatory
negative feedback loop may be evolutionary conserved.
Notably, both EAF1 and EAF2 have been shown to serve as
positive regulators for ELL in transcriptional elongation revealed
by in vitro assays [8]. Here, we provide evidences to show that EAF
gene family could also act as transcriptional repressors for directly
inhibiting Wnt4 expression by in vitro and in vivo assays. Although
the roles of EAF gene family in gene regulation are poorly
understood so far, regarding we have showed previously that EAF
gene family could up-regulate non-canonical wnt signaling ligand
wnt11 in zebrafish embryos [19], it implied that EAF gene family
might play important roles in regulating gene expression either
serving as activator or serving as inhibitor. However, the
mechanism underling these activities needs to be further
characterized.
Although we identified a regulatory relationship between Wnt4
(Wnt4a) and both EAF family members in zebrafish as well as
mammalian cells, we also noted differences. While Wnt4 (Wnt4a)
up-regulated EAF expression in both zebrafish embryos and 293
cells, the effect was more pronounced in the 293 cells. This
suggests that other factors may modify the ability of Wnt4 to
induce expression. The difference in factors may originate from
using an in vivo model versus a tissue culture model or may be
species specific. In addition, we observed a difference between
EAF1 and EAF2/U19: Wnt4 more strongly induced EAF2/U19
expression, which in turn more strongly suppressed Wnt4
Figure 4. Both zebrafish eaf1 and eaf2/u19 suppress zebrafish wnt4a expression. (A) Whole-mount in situ hybridization analysis of zebrafish
wnt4a expression in embryos injected with eaf1 mRNA, eaf2/u19 mRNA, Eaf1-MO and Eaf2-MO at 12-somite stage. The embryos without injection
were used as control. (B) The expression of zebrafish wnt4a mRNA was suppressed by ectopic expression of zebrafish eaf1 and eaf2/u19 (a) and up-
regulated by knockdown Eaf1 and Eaf2/U19 (b) as revealed by semi-quantitative RT-PCR analysis at 12-somte stage.
doi:10.1371/journal.pone.0009118.g004
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between Wnt4 and EAF2/U19 is more stringent than the loop
formed between Wnt4 and EAF1. In addition, even though wnt4
(wnt4a) affected the expression eaf1 and eaf2/u19 between
zebrafish embryos and human cells in a similar way, no obvious
conserved core elements in the promoter regions of either eaf1 or
eaf2/u19 could be identified between human and zebrafish. This
fact might suggest that non-canonical wnt4 (wnt4a) signals
influence eaf1 and eaf2/u19 expression through different molecular
mechanisms between zebrafish and mammalians.
EAF1 and EAF2/U19, the only two members in the EAF family
[4], share a high degree of sequence homology and a conserved
structure. Little is known regarding the function of EAF1, but
evidence clearly supports a tumor suppressive role for EAF2/U19.
Given the similarity of these proteins and their similar function in
the EAF-Wnt4 feedback loop, the possibility exists that EAF1
Figure 5. Both human EAF2/U19 and EAF1 are Wnt4 downstream factors. (A) The sequence of the 1.0 kb human EAF1 promoter and the
positions of primers used for subcloning. The transcriptional initial site is indicated by +1. (B) 293 cells were co-transfected with the EAF1 promoter
reporter and either a control vector or a vector expressing HA-Wnt4. The luciferase activity was normalized to Renilla and reported as the mean 6
standard deviation (SD). (C) The expression of Wnt4 was verified by Western blot using an anti-HA antibody. (D) The partial sequence of the 3.6 kb
human EAF2/U19 promoter and the primers used for subcloning. The transcriptional initial site is indicated by +1. (E) .293 cells were co-transfected
with the EAF2/U19 promoter reporter and either a control vector or a vector expressing HA-Wnt4. The luciferase activity was normalized to Renilla and
reported as the mean 6 SD.
doi:10.1371/journal.pone.0009118.g005
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observation that both EAF1 and EAF2/U19 participate with
Wnt4a in a negative feedback loop in zebrafish embryogenesis
may shed light on the tumor suppressive function of EAF proteins.
Indeed, several tumor suppressive factors, including the classic
tumor suppressor p53 gene family members p63 and p73, the
Wilms’ tumor suppressor WT1, and the cyclin/CDK inhibitor
p21 regulate Wnt4 expression [22,23,24]. P63, p73 and WT1
positively regulate transcription of Wnt4, while p21, directly
downstream of Notch1 activation, negatively regulates transcrip-
Figure 6. Western blot analysis of human endogenous EAF1
and EAF2/U19 protein expression after the introduction of
ectopic Wnt4 expression in 293 cells. (A) Representative Western
blot of EAF1 in 293 cells transfected with a control vector or a vector
expressing Wnt4 using a polyclonal antibody against human EAF1. (b)
EAF1 expression was normalized to b-actin. (B) Representative Western
blot of EAF2/U19 in 293 cells transfected with a control vector or a
vector expressing Wnt4 using a polyclonal antibody against human
EAF2/U19. (b) EAF2/U19 expression normalized to b-actin.
doi:10.1371/journal.pone.0009118.g006
Figure 7. Human Wnt4 expression is suppressed by human
EAF1 and EAF2/U19 in a human cell line. (A) 293 cells were
transfected with human Wnt4 promoter (1.2 kb and 2.6 kb)-reporter
constructs and a control vector or vectors expressing EAF1 or EAF2/U19.
Luciferase activity was normalized to Renilla and reported as the mean
6 SD. (B) (a) Endogenous Wnt4 expression in 293 cells is suppressed by
the over-expression of either EAF1 or EAF2/U19 as revealed by Northern
blot analysis. (b) Northern blots were quantitated and then normalized
to b-actin mRNA.
doi:10.1371/journal.pone.0009118.g007
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any tumors [23], the above observations suggest that Wnt4
signaling may contribute to tumor initiation or progression and
that the appropriate level of Wnt4 expression protects against
cancer, highlighting the potential importance of the EAF-Wnt4
feedback loop.
Interestingly, in addition to the difference of regulatory
stringency presented between EAF1-WNT4-EAF1 loop and
EAF2/U19-WNT4-EAF2/U19 loop, we also noticed that the
response elements in Wnt4 promoter accounting for EAF gene
suppression might not be the same based on the promoter and
ChIP assays. Eaf2/U19 suppressed the activity of the 1.2 kb
(21228 to -36) Wnt4 promoter in a statistically significant manner
(Fig. 7A, p,0.05) while EAF1 did not (Fig. 7A, p,0.08). In
addition, EAF1 could bind to the 21406 bp to 21102 bp region
of the Wnt4 promoter much more strongly than EAF2/U19 could,
as revealed by ChIP assays (Fig. 8A). Together, this data suggest
that the EAF1 response element for suppression on the Wnt4
promoter is probably localized to the region between 21406 bp to
21128 bp, while the EAF2/U19 response element is probably
between 21228 bp to 236 bp. A better understanding of the
functional difference between EAF1 and EAF2/U19 will help us
to better define the precise roles of EAF1 and EAF2/U19 in
embryogenesis and tumor suppression. However, due to the
relative low activity of Wnt4 promoter reporter in 293 cells, we
encountered a barrier to further define the core response elements
accounting for Eaf1 or Eaf2/U19’s suppression in the wnt4
promoter. In future, to search for suitable cell lines in which wnt4
promoter reporter exhibits higher activity might be helpful for
doing fine domain mapping in wnt4 promoter.
In summary, we provide evidence to showing that both EAF2/
U19 and EAF1 are downstream factors of Wnt4. Furthermore, we
identified a novel auto-regulatory negative feedback loop between
Wnt4 and the EAF gene family. Although the molecular
mechanisms underlying this loop require further definition, this
study has shed new light on the targets of non-canonical wnt4
(wat4a) signaling as well as has opened a new window for
understanding the mechanism of the EAF gene family in tumor
suppression.
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